# Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients

> **NCT01819441** · PHASE4 · UNKNOWN · sponsor: **Yining Huang** · enrollment: 1200 (estimated)

## Conditions studied

- Cerebral Small Vessel Diseases

## Interventions

- **DRUG:** Azelnidipine
- **DRUG:** Perindopril
- **DRUG:** hydrochlorothiazide

## Key facts

- **NCT ID:** NCT01819441
- **Lead sponsor:** Yining Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819441, "Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01819441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*